Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China ready to show itself to the world at Medica

This article was originally published in Clinica

Executive Summary

The majority of China's medical device manufacturers produce high-volume, low added-value products. But there is a discernible trend towards high-tech products, says a report in China Medical Device Manufacturing (CMDM) online magazine. A record number of high-tech Chinese manufacturers are expected to be present at the Medica trade fair (Dusseldorf, Germany) in November. Chinese exhibitors are expected to number around 400 (+33%), and many of them are offering high-technology products, in a bid to compete with US and European multinationals. Chinese manufacturers are realising that price wars are not an effective long-term strategy for medtech companies and are realising the need to offer quality and added value. "It is very important to invest in R&D and proprietary technologies", says Ting Yang, CEO of Shenzhen-based Mindray (patient monitors, clinical laboratory instruments and reagents and ultrasound imaging systems).

You may also be interested in...

Dr Reddy's Adds To OTC Portfolio With Glenmark Deal

Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.

Sandoz Launches US Awareness Campaign

Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.

EU Plans IP Law Shake-Up

European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts